ArticleBMC pediatrics2025
Predictive value of inflammatory indices for disease severity and perinatal outcomes in intrahepatic cholestasis of pregnancy.
Article in BMC pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Maternal Serum SIRT1 Concentrations in Intrahepatic Cholestasis of Pregnancy: Limited Diagnostic Utility in a Prospective Case-Control Study.Diagnostics (Basel, Switzerland) · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe etiology of intrahepatic cholestasis of pregnancy (ICP) is not fully understood; however, genetic, hormonal, environmental factors, and inflammation are believed to contribute to its development. This study aimed to investigate the relationship between systemic immune-inflammation index (SII), systemic inflammatory response index (SIRI), and neutrophil-to-monocyte ratio (NMR) levels with disease severity in ICP and to evaluate their potential in predicting adverse perinatal outcomes. MATERIALS AND
methodsA total of 240 pregnant women who delivered at Bursa City Hospital between 2019 and 2024 were retrospectively analyzed. Based on fasting serum bile acid (SBA) levels, patients were divided into three groups: control (SBA < 10 µmol/L), mild (SBA 10-40 µmol/L), and severe (SBA ≥ 40 µmol/L) cholestasis. Inflammatory indices were calculated using complete blood count. Blood samples had been collected at the time of diagnosis, between 28 and 36 weeks of gestation during the third trimester, and prior to the initiation of any treatment. Intergroup comparisons and correlation analyses were conducted. The predictive value of these indices was assessed using receiver operating characteristic (ROC) analysis.
resultsNo significant differences were found between groups in WBC and other complete blood count parameters. Only NMR was significantly higher in the severe cholestasis group compared to the control group (p = 0.0057). SII and SIRI levels did not differ significantly among the groups. Gestational age at delivery, birth weight, Apgar scores, and neonatal intensive care unit (NICU) admission rates were significantly worse in the cholestasis groups than in controls (p < 0.001). SII showed a negative correlation with gestational age and 5th-minute Apgar score. In ROC analysis, SII predicted preterm birth with an AUC of 0.600 (cut-off: 897.35; sensitivity: 57%; specificity: 67%) and predicted low 5th-minute Apgar scores with an AUC of 0.669 (cut-off: 1248.38; sensitivity: 75%; specificity: 83%).
conclusionThe SII and the SIRI may not be reliable markers for the diagnosis or severity assessment of ICP. However, the SII may serve as a potential predictor for preterm birth and low Apgar scores. NMR was significantly elevated in severe ICP patients, suggesting its potential diagnostic value, which should be supported by further studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.